Impact of Age and Sex on Response to Asthma Therapy.

PubWeight™: 1.43‹?› | Rank: Top 5%

🔗 View Article (PMID 26068329)

Published in Am J Respir Crit Care Med on September 01, 2015

Authors

Ryan M Dunn1, Erik Lehman2, Vernon M Chinchilli2, Richard J Martin1, Homer A Boushey3, Elliot Israel4, Monica Kraft5, Stephen C Lazarus3, Robert F Lemanske6, Njira L Lugogo5, Stephen P Peters7, Christine A Sorkness6, Stanley Szefler8, Michael E Wechsler1, NHLBI Asthma Clinical Research Network

Author Affiliations

1: 1 National Jewish, Denver, Denver, Colorado.
2: 2 Penn State University, Hershey, Pennsylvania.
3: 3 University of California-San Francisco, San Francisco, California.
4: 4 Brigham and Women's Hospital, Boston, Massachusetts.
5: 5 Duke University, Durham, North Carolina.
6: 6 University of Wisconsin-Madison, Madison, Wisconsin.
7: 7 Wake Forest University, Winston-Salem, North Carolina; and.
8: 8 Children's Hospital Colorado, University of Colorado School of Medicine, Aurora, Colorado.

Articles cited by this

The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol. Chest (2006) 8.43

Lebrikizumab treatment in adults with asthma. N Engl J Med (2011) 8.07

Daily versus as-needed corticosteroids for mild persistent asthma. N Engl J Med (2005) 7.61

Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program. Am J Respir Crit Care Med (2009) 7.17

Long-acting beta2-agonist monotherapy vs continued therapy with inhaled corticosteroids in patients with persistent asthma: a randomized controlled trial. JAMA (2001) 6.55

Cluster analysis and clinical asthma phenotypes. Am J Respir Crit Care Med (2008) 5.80

Tiotropium in asthma poorly controlled with standard combination therapy. N Engl J Med (2012) 5.64

Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trial. Lancet (2004) 5.01

A 15-year follow-up study of ventilatory function in adults with asthma. N Engl J Med (1998) 4.52

Comparison of physician-, biomarker-, and symptom-based strategies for adjustment of inhaled corticosteroid therapy in adults with asthma: the BASALT randomized controlled trial. JAMA (2012) 4.30

Comparison of regularly scheduled with as-needed use of albuterol in mild asthma. Asthma Clinical Research Network. N Engl J Med (1996) 4.03

Significant variability in response to inhaled corticosteroids for persistent asthma. J Allergy Clin Immunol (2002) 3.66

Inhaled corticosteroid reduction and elimination in patients with persistent asthma receiving salmeterol: a randomized controlled trial. JAMA (2001) 3.21

Smoking affects response to inhaled corticosteroids or leukotriene receptor antagonists in asthma. Am J Respir Crit Care Med (2007) 2.81

Underdiagnosis and undertreatment of asthma in the elderly. Cardiovascular Health Study Research Group. Chest (1999) 2.51

Impact of gender on asthma in childhood and adolescence: a GA2LEN review. Allergy (2007) 2.35

Rate of decline of lung function in subjects with asthma. Eur J Respir Dis (1987) 2.27

Decline in lung function in the Busselton Health Study: the effects of asthma and cigarette smoking. Am J Respir Crit Care Med (2004) 2.27

Systemic effect comparisons of six inhaled corticosteroid preparations. Am J Respir Crit Care Med (2002) 2.24

Reduced subjective awareness of bronchoconstriction provoked by methacholine in elderly asthmatic and normal subjects as measured on a simple awareness scale. Thorax (1992) 2.11

The Predicting Response to Inhaled Corticosteroid Efficacy (PRICE) trial. J Allergy Clin Immunol (2007) 1.87

Effect of vitamin D3 on asthma treatment failures in adults with symptomatic asthma and lower vitamin D levels: the VIDA randomized clinical trial. JAMA (2014) 1.67

Differences in incidence of reported asthma related to age in men and women. A retrospective analysis of the data of the European Respiratory Health Survey. Am J Respir Crit Care Med (2000) 1.66

Impact of race on asthma treatment failures in the asthma clinical research network. Am J Respir Crit Care Med (2011) 1.63

Combination therapy with a long-acting beta-agonist and a leukotriene antagonist in moderate asthma. Am J Respir Crit Care Med (2006) 1.46

Body mass index and phenotype in subjects with mild-to-moderate persistent asthma. J Allergy Clin Immunol (2009) 1.43

Age-related changes in immune function: effect on airway inflammation. J Allergy Clin Immunol (2010) 1.29

Decline of lung function in adults with bronchial asthma. Am J Respir Crit Care Med (1994) 1.27

Prospective multicenter study of acute asthma in younger versus older adults presenting to the emergency department. J Am Geriatr Soc (2006) 1.24

Age-related changes in eosinophil function in human subjects. Chest (2008) 1.22

Gender differences in prevalence, diagnosis and incidence of allergic and non-allergic asthma: a population-based cohort. Thorax (2012) 1.22

Epithelial interleukin-25 is a key mediator in Th2-high, corticosteroid-responsive asthma. Am J Respir Crit Care Med (2014) 1.09

Standardised mortality rates in females and males with COPD and asthma. Eur Respir J (2005) 1.05

Induction and maintenance of airway responsiveness to allergen challenge are determined at the age of initial sensitization. J Immunol (2004) 0.94

Changes in FVC during methacholine-induced bronchoconstriction in elderly patients with asthma: bronchial hyperresponsiveness and aging. Chest (2001) 0.92

Pathophysiological characteristics of asthma in the elderly: a comprehensive study. Ann Allergy Asthma Immunol (2014) 0.86